Cite
HARVARD Citation
Pagliarini, S. et al. (2014). A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study. Journal of ophthalmology. p. . [Online].